The following is a summary of “Efficacy and Safety of Robot-assisted AUS Implantation Surgery in Treating Severe Stress Urinary Incontinence: A Systematic Review and Meta-Analysis,” published in the JANUARY 2023 issue of Urology by Yuanzhuo, et al.
For a systematic literature review, researchers sought to assess the safety and effectiveness of robot-assisted artificial urinary sphincter (AUS) implantation surgery for severe stress urinary incontinence (SUI) in female patients.
They conducted a comprehensive search in multiple databases, including PubMed, EMBASE, Web of Science Clarivate, Cochrane library, Medicine, and clinicaltrials.gov, from inception to March 2022. A total of 9 studies, including 157 participants, were included in the final analysis. Of these studies, 8 were retrospective, and 1 was prospective, with moderate and high evidence levels.
The pooled results showed that robot-assisted AUS implantation treatment had an excellent continence rate (P = 0.83, 95% CI: 0.76-0.89) but a high complication rate, including intraoperative vaginal and bladder injury and postoperative acute urinary retention (Intraoperation: 0.21, 95% CI: 0.11-0.34; Postoperation: 0.20, 95% CI: 0.12-0.29). In addition, subgroup analysis of the two approaches showed that the traditional surgical approach had better efficacy and safety than the posterior approach.
In conclusion, the study’s results suggested that robot-assisted AUS implantation surgery can improve urinary continence in SUI patients, but it is associated with high complication rates. More evidence from prospective studies was needed to guide clinical practice.